ArticleScientific reports2026
An intelligent healthcare framework for hepatocellular carcinoma diagnosis based on aggregated learners from biomedical data utilising explainable artificial intelligence.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent days, biomedical data mining and machine learning (ML) technologies have transformed the healthcare sector, which utilises cutting-edge medical innovative tools to develop effective decision support systems for disease diagnosis and health informatics. Liver cancer (LC) is a major contributor to the global cancer problem. Incidence rates of this disease have improved in several countries in the past decades. As the main histological kind of LC, hepatocellular carcinoma (HCC) constitutes the large majority of LC diagnoses and deaths. HCC is one of the primary reasons for cancer occurrence and fatality. Initial diagnosis of HCC remains the main aim in improving the poor diagnosis of this type of LC. Recognising HCC at an initial stage is frequently related to improved treatment possibilities for patients with small and symptomless tumours. Several artificial intelligence (AI) methods are considered advanced methods for processing and handling composite multimodal data ranging from repetitive clinical variables to higher-resolution medical images. This paper presents a Hepatocellular Carcinoma Diagnosis based on an Aggregated Learners Utilising Explainable Artificial Intelligence (HCDAL-XAI) model from biomedical data. The primary purpose of the HCDAL-XAI model is to deliver an accurate detection model for initial diagnosis and efficient treatment of HCC using progressive methods. Initially, the data pre-processing step uses min-max normalisation. Furthermore, the HCDAL-XAI model employs an ensemble of a sparse autoencoder (SAE), gated recurrent unit (GRU), and deep belief network (DBN) for the classification process. Lastly, the explainable AI (XAI) model employs SHapley Additive exPlanations (SHAP) to enhance the reliability of AI methods by making their decision-making processes understandable to humans. The comparison analysis of the HCDAL-XAI methodology portrayed a greater accuracy value of 98.18% over existing models under the HCC dataset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.